These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 22521321

  • 1. Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes.
    Fogarty RD, Abhary S, Javadiyan S, Kasmeridis N, Petrovsky N, Whiting MJ, Craig JE, Burdon KP.
    J Diabetes Complications; 2012; 26(3):195-8. PubMed ID: 22521321
    [Abstract] [Full Text] [Related]

  • 2. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, Petrovsky N, Craig JE.
    PLoS One; 2010 Mar 01; 5(3):e9462. PubMed ID: 20209122
    [Abstract] [Full Text] [Related]

  • 3. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug 01; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 4. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
    Tanhäuserová V, Tomandl J, Pácal L, Klepárník M, Malúšková D, Bartáková V, Kuricová K, Rehořová J, Stěpánková S, Svojanovský J, Olšovský J, Bělobrádková J, Krusová D, Jurajda M, Mužík J, Pavlík T, Kaňková K.
    Kidney Blood Press Res; 2012 Aug 01; 36(1):200-8. PubMed ID: 23147199
    [Abstract] [Full Text] [Related]

  • 5. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, Spazzafumo L, Testa I, Bonfigli AR, Cucchi M, Testa R.
    Nephrol Dial Transplant; 2013 Apr 01; 28(4):964-71. PubMed ID: 23129820
    [Abstract] [Full Text] [Related]

  • 6. Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.
    Dimitroulas T, Sandoo A, Hodson J, Smith J, Panoulas VF, Kitas GD.
    Atherosclerosis; 2014 Nov 01; 237(1):38-44. PubMed ID: 25194333
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M, Liu L, Guo Z, Xiong Y.
    Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M, Maass LM, Diemert A, Lüneburg N, Atzler D, Hecher K, Böger RH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr 14; 161(2):152-6. PubMed ID: 22285683
    [Abstract] [Full Text] [Related]

  • 15. ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
    Rodionov RN, Heinrich A, Brilloff S, Jarzebska N, Martens-Lobenhoffer J, Bode-Böger SM, Todorov VT, Hugo CPM, Weiss N, Hohenstein B.
    Atheroscler Suppl; 2017 Nov 14; 30():319-325. PubMed ID: 29096857
    [Abstract] [Full Text] [Related]

  • 16. DDAH gene and cardiovascular risk.
    Valkonen VP, Tuomainen TP, Laaksonen R.
    Vasc Med; 2005 Jul 14; 10 Suppl 1():S45-8. PubMed ID: 16444868
    [Abstract] [Full Text] [Related]

  • 17. Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine in coronary artery disease.
    Gad MZ, Hassanein SI, Abdel-Maksoud SM, Shaban GM, Abou-Aisha K, Elgabarty HA.
    Biomarkers; 2010 Dec 14; 15(8):746-52. PubMed ID: 20936901
    [Abstract] [Full Text] [Related]

  • 18. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T.
    Hypertens Res; 2005 Mar 14; 28(3):255-62. PubMed ID: 16097370
    [Abstract] [Full Text] [Related]

  • 19. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.
    Circ Res; 2007 Jul 20; 101(2):e2-10. PubMed ID: 17601800
    [Abstract] [Full Text] [Related]

  • 20. A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.
    Mannino GC, Pezzilli S, Averta C, Fuoco A, Spiga R, Mancuso E, Di Fatta C, Perticone F, Prudente S, Trischitta V, Andreozzi F, Sesti G.
    Cardiovasc Diabetol; 2019 Aug 13; 18(1):102. PubMed ID: 31409409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.